State Clinical Trials Law
Nev. Rev. Stat. Ann. §§ 689A.04033, 689B.0306, 695B.1903, 695C.1693, 695G.173
Who must cover the costs? All health insurers, medical service corporations, HMOs, and managed care organizations
What must be covered? Routine patient care costs associated with Phase I, II, III, and IV cancer clinical trials
Requirements for Coverage: The healthcare facility and personnel conducting the study must have experience and training to provide the treatment in a capable manner. There must be no medical treatment available that is considered a more effective alternative treatment than the experimental treatment. Finally, there must be reasonable expectation based on clinical data that the treatment provided in the trial will be at least as effective as any other medical treatment.
Qualifying Trials: The clinical trial must be approved by one of the following: (1) NIH, (2) U.S. F.D.A. as an application for a new investigational drug, (3) U.S. Dept. of Veterans Affairs, (4) U.S. Dept. of Defense, or (5) a cooperative group.
(Current as of 8/2022)